DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $25,196,000 | -63.6% | 1,249,812 | -54.1% | 0.88% | -82.8% |
Q2 2020 | $69,139,000 | +12.5% | 2,721,993 | -18.7% | 5.11% | -20.5% |
Q1 2020 | $61,472,000 | -23.1% | 3,346,301 | -7.8% | 6.42% | -10.8% |
Q4 2019 | $79,916,000 | +40.4% | 3,627,597 | -8.5% | 7.20% | +0.2% |
Q3 2019 | $56,908,000 | +9.0% | 3,962,978 | +19.5% | 7.19% | +36.2% |
Q2 2019 | $52,233,000 | +7.5% | 3,316,407 | 0.0% | 5.28% | +17.8% |
Q1 2019 | $48,585,000 | +37.0% | 3,316,407 | 0.0% | 4.48% | +26.3% |
Q4 2018 | $35,452,000 | -38.9% | 3,316,407 | -12.8% | 3.55% | -32.1% |
Q3 2018 | $58,024,000 | +60.0% | 3,802,327 | +28.4% | 5.23% | +51.4% |
Q2 2018 | $36,274,000 | -20.4% | 2,961,147 | -37.8% | 3.45% | -24.4% |
Q1 2018 | $45,548,000 | +4.3% | 4,764,447 | -1.5% | 4.57% | -7.1% |
Q4 2017 | $43,674,000 | +692.9% | 4,836,547 | +404.9% | 4.92% | +570.0% |
Q3 2017 | $5,508,000 | +126.2% | 957,992 | +24.7% | 0.73% | +69.9% |
Q2 2017 | $2,435,000 | +87.5% | 767,992 | +101.0% | 0.43% | +31.7% |
Q1 2017 | $1,299,000 | – | 382,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |